Quick links

networking & contacts

look back at 2009

130+ participants

In excess of 75 individual organisations represented

33 hours of presentations

Over 10 hours of networking

91% of our attendees ranked the congress as good or excellent

30 different countries

› Benefits of sponsoring

conference details

Conference:

Pre-conference workshop

23 Feb 9am - 5pm

Day 1

24 Feb 8.30am - 6:00pm

Day 2

25 Feb 8.30am - 5:30pm

Post-conference workshop

26 Feb 9am - 5pm

Venue:
The Royal Horseguards Hotel, London, United Kingdom

› Email a friend
› Add this to my calendar

or call +44 (0) 207 608 7055

conference:

speaker faq

delegate faq

Patrick Vink, speaking at World Generic Medicines Congress Europe 2010

Patrick Vink,
Senior Vice President, Head of Global Biologics
Mylan GmbH

Patrick Vink is a citizen of the Netherlands, who, in addition to his doctorate of Medicine holds a post-doctorate Masters of Business Administration. Starting his professional career in the 80ies he held different positions at the Dutch affiliate of Sanofi until he became general manager Nutricia (a dutch babyfood company) in Hungary. Returning at Sanofi in Paris he was appointed as Vice-President global business unit Cardiovascular & Thrombosis. After joining Biogen he served as Vice-President Sales International. In 2002 he became a member of the worldwide executive committee at Sandoz as Global Head Business Unit Biopharmaceuticals at Sandoz. In this role he lad Sandozs activities in the Follow-on Biologics area. After leaving Sandoz in 2006, he was an independent advisor in the Life Sciences Industry and Investors in this industry. Per March 1, 2008 he is appointed at Mylan, holding global responsibility for all biologics business.

Appearing:

Day one - Wed 24 Feb 2010

4.15pm

Global review of biosimilar development

• Market development over the coming years: what is the opportunity?

• Regulatory developments around the world

• Biosimilars vs. biobetters: what’s the difference and how does it impact strategy?

• How to develop a successful business model

Patrick Vink,

Senior Vice President, Head of Global Biologics,
Mylan GmbH

back to programme »

back to speaker list »

event sponsors

Sponsor:

twitter with us!

› twitter with us!

our speakers

Robert Wessman

Executive Chairman

Alvogen

Petra Danielsohn-Weil

European President, Established Brands

Pfizer

Satish Reddy

Chief Operating Officer & Managing Director

Dr Reddy's Laboratories

Gerard van Odijk

President & Chief Executive Officer

Teva Pharmaceuticals Europe

Honorable Henry A Waxman

Member of Congress

United States of Americas

Patrick Vink,Senior Vice President, Head of Global BiologicsMylan GmbH

Global review of biosimilar development

Patrick Vink,
Senior Vice President, Head of Global Biologics
Mylan GmbH